Nai-xia Zhang
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
19F qNMR based pharmacokinetics, metabolism and mass balance studies of SARS-CoV-2-3CL protease inhibitor simnotrelvir (SIM0417) in humans.
Journal: Acta pharmacologica Sinica
Published: May 26, 2024
Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer.
Journal: British journal of pharmacology
Published: October 17, 2022
Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule.
Journal: Acta pharmacologica Sinica
Published: January 18, 2021
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase.
Journal: Acta pharmacologica Sinica
Published: December 17, 2020
An enhanced targeted identification strategy for the selective identification of flavonoid O-glycosides from Carthamus tinctorius by integrating offline two-dimensional liquid chromatography/linear ion-trap-Orbitrap mass spectrometry, high-resolution diagnostic product ions/neutral loss filtering and liquid chromatography-solid phase extraction-nuclear magnetic resonance.
Journal: Journal of chromatography. A
Published: November 21, 2016
NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds.
Journal: Acta pharmacologica Sinica
Published: February 15, 2016
Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.
Journal: Acta pharmacologica Sinica
Published: September 18, 2013
Progress in the fragment-based drug discovery
Journal: Yao xue xue bao = Acta pharmaceutica Sinica
Published: April 23, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026